About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life, and half ...
Most adults (62%) say they have taken a GLP-1 drug to treat a chronic condition including diabetes or heart disease, while 43 ...
One in eight adults (12 percent) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and 6 percent say they are currently using one, ...
GLP-1s have exploded in popularity, to the where, a ccording to the Kaiser Family Foundation, 12% of adults has taken Ozempic ...
Structure Therapeutics reported Monday that its oral GLP-1 drug led to weight loss in two studies, leading shares to surge in ...
Agents in development would preserve lean body mass and further promote fat loss in people taking new antiobesity medications ...
More than three out of four young adults prescribed GLP-1 drugs last year were women, new research shows–raising questions ...
Medications for type 2 diabetes and obesity known as GLP-1 receptor agonists may lower the risk of acute pancreatitis recurrence in people with obesity and those with type 2 diabetes, according to a ...
"Does your insurance cover anti-obesity drugs?" Laura Davisson, MD, once again asked the patient before her. She said these cost-of-care conversations are now a daily occurrence. While glucagon-like ...
Injected medications that treat diabetes and obesity increase the risk of a rare but serious side effect: stomach paralysis, ...
Nestlé has created a new frozen food line, aimed at people taking GLP-1 medications. Experts say maintaining a healthy diet ...
As the global focus on health and weight management intensifies, Nestle has announced the launch of Vital Pursuit, a brand ...